Evaluation of the Effect of Botulinum Toxin Type-A Injection Prior to Surgical Correction of Complete Unilateral Cleft Lip Repair by Modified Millard Cheiloplasty

Evaluation of the Effect of Botulinum Toxin Type-A Injection Prior to Surgical Correction of Complete Unilateral Cleftlip Repair by Modified Millard Cheiloplasty

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03047499

Enrollment

Registered

2017-02-09

Start date

2017-02-15

Completion date

2017-11-15

Last updated

2017-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esthetic Outcome of Injection of Botulinum Toxin Type-A in Cleft Lip Repair

Brief summary

Evaluation of the effect of botulinum toxin type-A injection prior to surgical correction of complete unilateral cleftlip repair by modified millard cheiloplasty

Interventions

DRUGBotulinum toxin type A

Botulinum toxin type-A injection

Study design

Observational model

CASE_CONTROL

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

3 Months to 6 Months

Inclusion criteria

* Primary cleft lip

Exclusion criteria

* Cleft palate

Design outcomes

Primary

Measure	Time frame
Scar Length	6 months

Countries

Egypt

Contacts

Primary ContactMostafa Ayman Khairy

mostafakhairy100@hotmail.com00201001155527

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026